References
- Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009;9(6):2950–2967.
- Shimpi MR, Alhayali A, Cavanagh KL, et al. Tadalafil-malonic acid cocrystal: physicochemical characterization, pH-solubility, and supersaturation studies. Cryst Growth Des. 2018;18(8):4378–4387.
- Keramatnia F, Shayanfar A, Jouyban A. Thermodynamic solubility profile of carbamazepine-cinnamic acid cocrystal at different pH. J Pharm Sci. 2015;104(8):2559–2565.
- Bala M, Gautam MK, Chadha R. What if cocrystallization fails for neutral molecules? screening offered eutectics as alternate pharmaceutical materials: leflunomide-a case study. Pharm Sci. 2019;25(3):235–243.
- Fandiño OE, Bruno FP, Monti GA, et al. Mechanochemical synthesis of a novel eutectic of the antimicrobial nitazoxanide with improved dissolution performance. Pharm Sci. 2021;27(4):585–592.
- Aakeröy CB, Fasulo ME, Desper J. Cocrystal or salt: does it really matter? Mol Pharm. 2007;4(3):317–322.
- Kavanagh ON, Croker DM, Walker GM, et al. Pharmaceutical cocrystals: from serendipity to design to application. Drug Discov Today. 2019;24(3):796–804.
- Thakuria R, Sarma B. Drug-drug and drug-nutraceutical cocrystal/salt as alternative medicine for combination therapy: a crystal engineering approach. Crystals. 2018;8(2):101.
- Shayanfar A, Asadpour-Zeynali K, Jouyban A. Solubility and dissolution rate of a carbamazepine-cinnamic acid cocrystal. J Mol Liq. 2013;187:171–176.
- Trask AV, Motherwell WDS, Jones W. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm. 2006;320(1–2):114–123.
- Gupta D, Bhatia D, Dave V, et al. Salts of therapeutic agents: chemical, physicochemical, and biological considerations. Molecules. 2018;23(7):1719.
- Ainurofiq A, Mauludin R, Mudhakir D, et al. Evaluation of thermal-induced polymorphic transformation on desloratadine and desloratadine-benzoic acid salt. Pharm Sci. 2020;26(4):399–405.
- Ito M, Nambu K, Sakon A, et al. Mechanisms for improved hygroscopicity of l-arginine valproate revealed by x-ray single crystal structure analysis. J Pharm Sci. 2017;106(3):859–865.
- Kobayashi Y, Ito S, Itai S, et al. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int J Pharm. 2000;193(2):137–146.
- Uzunović A, Vranić E, Hadžidedić S. Impairment of the in vitro release of carbamazepine from tablets. Bosn J Basic Med Sci. 2010;10(3):234–238.
- Cao F, Amidon GL, Rodriguez-Hornedo N, et al. Mechanistic analysis of cocrystal dissolution as a function of pH and micellar solubilization. Mol Pharm. 2016;13(3):1030–1046.
- Moradiya HG, Islam MT, Halsey S, et al. Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing. Crystengcomm. 2014;16(17):3573–3583.
- Lu C, Leibner E, Wright B. The use of tris-hydroxymethyl aminomethane in the emergency department. Clin Exp Emerg Med. 2016;3(4):264–265.
- Farina J, Brittain HG. Tromethamine salt of valproic acid. 2007. WO2007015724. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2007015724
- Greenspan L. Humidity fixed points of binary saturated aqueous solutions. J Res Natl Bur Stan Sect A. 1977;81A(1):89–96.
- Feng Y, Meng Y, Tan F, et al. Effect of surfactants and polymers on the dissolution behavior of supersaturable tecovirimat-4-hydroxybenzoic acid cocrystals. Pharmaceutics. 2021;13(11):1772.
- Sun DD, Wen H, Taylor LS. Non-sink dissolution conditions for predicting product quality and in vivo performance of supersaturating drug delivery systems. J Pharm Sci. 2016;105(9):2477–2488.
- Maghsoodi M, Narimanpour O. Improved dissolution behavior of dipyridamole formulation with precipitation inhibitor. Pharm Sci. 2020;26(3):314–322.
- Childs SL, Stahly GP, Park A. The salt-cocrystal continuum: the influence of crystal structure on ionization state. Mol Pharm. 2007;4(3):323–338.
- Grzesiak AL, Lang M, Kim K, et al. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci. 2003;92(11):2260–2271.
- Patil S, Xalxo K, Mahadik K. Probing influence of solvent on polymorphic transformation of carbamazepine using electrospray technology. J Pharm Innov. 2017;12(4):309–318.